STEM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
STEM is not a good buy right now. Despite being deeply oversold (RSI ~18.8), price action remains bearish (MACD histogram negative and expanding), the stock just fell ~6.1% in the regular session, and insiders are aggressively selling (selling up ~535.6% over the last month). With no Intellectia buy signals today and mixed-to-bearish options flow (heavy put volume), the higher-probability move is continued volatility/downside toward the next support rather than a clean reversal you can rely on immediately.
Trend/Momentum: Bearish. MACD histogram is -0.364 and negatively expanding, signaling downside momentum is strengthening rather than stabilizing. RSI(6) at 18.782 indicates extreme oversold, which can produce sharp bounces, but oversold alone is not a reversal signal. Key levels: Current ~15.6 is below S1 16.067 (near-term breakdown). Next support S2 is 14.625. Pivot resistance is 18.401; a reclaim/hold above that pivot would be a more credible trend improvement. R1 20.735 is the next upside target only if momentum flips. Moving averages: Converging MAs suggest a potential base attempt, but with current momentum negative, the convergence is not yet translating into upside control. Pattern-based odds (provided): 40% chance to gain ~3.85% next day, ~5.74% next week, ~2.45% next month—helpful for bounce potential, but not strong enough to override the current breakdown below support and insider selling.
quickly.
Price trend is currently bearish with accelerating downside momentum (MACD histogram negative and expanding) and a sharp -6.14% regular-session drop.
Insiders are selling aggressively (selling up ~535.60% over the last month), a meaningful near-term confidence overhang.
Options tape is bearish today (put volume heavily dominates; volume P/C 4.22).
Profitability is deteriorating: Q3 2025 net income fell to -23.791M (down -83.96% YoY) and EPS dropped to -2.84 (down -84.43% YoY), increasing the risk that any rally is sold.
No supportive news flow in the past week to counter the downtrend; next major narrative catalyst is earnings, which also adds event risk.
Latest quarter: 2025/Q3. Revenue increased to $38.237M (+30.54% YoY), and gross margin improved to 35.52 (+60.14% YoY), indicating better unit economics. However, bottom-line performance worsened materially: net income declined to -$23.791M (down -83.96% YoY) and EPS dropped to -2.84 (down -84.43% YoY). Overall: strong top-line and margin improvement, but losses are expanding—growth quality is improving at the gross level, yet operating/other costs are still pressuring earnings.
No analyst rating/price target change data was provided, so a verified recent trend cannot be summarized. Based on the data on hand, Wall Street-style pros would center on accelerating revenue growth and improving gross margin (path to operating leverage). Cons would focus on the sharply worsening net loss/EPS and the heavy insider selling signal. Net: fundamentals are mixed, but the market is currently pricing the stock with bearish momentum.
